Search results for

The Supreme Court in New Delhi has laid down guidelines to avoid the registration of deceptively similar trade marks. Saying there should be the maximum possible number of indicators to distinguish two medicinal products, the Court has drawn up a broad seven-point set of rules on the registration of trade marks for medicines.

Patent infringement litigation involves a large number of uncertainties. Alexander I Poltorak and Paul J Lerner reveal how to calculate the risk involved

Electronic filing is the future. The European Patent Office’s new website offers that and much, much more. James Nurton takes a sneak preview at epoline.org

A new set of amendments to the Patent Law of the People’s Republic of China will enter into force in July 2001. Elizabeth Chien-Hale examines the revisions to the compulsory licensing provisions

Jeremy Phillips looks again at the function of trade marks in the light of three cases which are heading towards the ECJ

Two of Asia's biggest names in IP have joined together to form a new specialized practice in Singapore. IP law firm Ella Cheong & G Mirandah and patent and trade mark attorneys Spruson & Ferguson Pte Ltd, the Singapore branch of Australia's Spruson & Ferguson, will be launched formally on June 6. But the new firm, Ella Cheong Mirandah & Sprusons, is already open for business. The link between the two Singapore firms was announced during the AIPPI congress in Melbourne in the last week of March. It is expected that all staff from Sprusons's Singapore office and from Ella Cheong & G Mirandah will join the new set-up. Cheong is retiring as a partner of Wilkinson & Grist, the Hong Kong law firm, and will chair Ella Cheong Mirandah & Sprusons.

Has the European Court of Justice given the green light to parallel imports into Europe? Tesco says yes; Levi’s says no. Many lawyers say it is a bit more complicated than that. Tabitha Parker reports

Recent changes to patent law and PTO prosecution in the US make prosecution a much more complex matter. Gregory J Maier and Philippe Signore take a close look at the reforms

US membership of the Madrid Protocol may be only a few months away according to Bruce MacPherson, director of external affairs of the International Trademark Association. Thanks to pressure from US companies and the INTA, the legislation to implement membership, first considered in 1989, is nearing the end of its journey through Congress. Attempts to implement the Protocol have not been easy. It has been dogged by conflict with the EU, and lately by complications over Cuba's role.

A federal judge has ruled that Mylan Laboratories must be allowed to sell its generic copy of Bristol-Myers Squibb's highly profitable drug BuSpar.